APA

Delmas P. D., Recker R. R., Chesnut C. H., Skag A., Stakkestad J. A., Emkey R., Gilbride J., Schimmer R. C. & Christiansen C. (20041116). Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Chicago

Delmas P D, Recker R R, Chesnut C H, Skag A, Stakkestad J A, Emkey R, Gilbride J, Schimmer R C and Christiansen C. 20041116. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Harvard

Delmas P. D., Recker R. R., Chesnut C. H., Skag A., Stakkestad J. A., Emkey R., Gilbride J., Schimmer R. C. and Christiansen C. (20041116). Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

MLA

Delmas P D, Recker R R, Chesnut C H, Skag A, Stakkestad J A, Emkey R, Gilbride J, Schimmer R C and Christiansen C. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 20041116.